Phase II trial of combination therapy with bortezomib, pegylated liposomal doxorubicin, and dexamethasone in patients with newly diagnosed myeloma.

Source:http://linkedlifedata.com/resource/pubmed/id/19738129

J. Clin. Oncol. 2009 Oct 20 27 30 5015-22

Download in:

View as

Triples

General Info

PMID
19738129